MOMP, cell suicide as a BCL-2 family business.
Kalkavan H, Green DR. · 2018
Read MOMP, cell suicide as a BCL-2 family business. by Kalkavan H, Green DR. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5729535.txt.
Introduction
Kalkavan and Green review how mitochondria trigger orderly cell death. The key step is permeabilization of the outer mitochondrial membrane, called MOMP. Once that barrier opens, proteins stored inside spill out. Those proteins switch on caspases, the enzymes that dismantle the cell.
The review covers cytochrome c and SMAC, two of the released proteins. It also covers the BCL-2 family, which sets the balance between life and death upstream. Partial membrane opening, the authors note, can cause harm without full death. Better maps of these checkpoints may guide new cancer drugs.
Catalog record
| CREATOR | Kalkavan H, Green DR. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
MOMP, cell suicide as a BCL-2 family business By Halime Kalkavan, Douglas R Green Published in: Cell Death and Differentiation DOI: 10.1038/cdd.2017.179 ABSTRACT Abstract Apoptosis shapes development and differentiation, has a key role in tissue homeostasis, and is deregulated in cancer. In most cases, successful apoptosis is triggered by mitochondrial outer membrane permeabilization (MOMP), which defines the mitochondrial or intrinsic pathway and ultimately leads to caspase activation and protein substrate cleavage. The mitochondrial apoptotic pathway centered on MOMP is controlled by an intricate network of events that determine the balance of the cell fate choice between survival and death. Here we will review how MOMP proceeds and how the main effectors cytochrome c, a heme protein that has a crucial role in respiration, and second mitochondria-derived activator of caspase (SMAC), as well as other intermembrane space proteins, orchestrate caspase activation. Moreover, we discuss recent insights on the interplay of the upstream coordinators and initiators of MOMP, the BCL-2 family. This review highlights how our increasing knowledge on the regulation of critical checkpoints of apoptosis integrates with understanding of cancer development and has begun to translate into therapeutic clinical benefit. Graphical Abstract FACTS - The interaction of BCL-2 family members orchestrates mitochondrial outer membrane permeabilization (MOMP) and can thereby translate cellular stresses into apoptosis initiation. - In addition to protein–protein interactions within the BCL-2 family, BCL-2 effector proteins can be regulated directly by post-translational modifications. - The mitochondrial intermembrane space harbors proteins (e.g., cytochrome c, SMAC, Omi) that are involved in caspase activation. - Apoptosis via the intrinsic pathway requires nearly complete MOMP; partial MOMP can lead to pathophysiology. OPEN QUESTIONS - How do specific BCL-2 family members relate to cell-type-dependent stress responses? - How does BOK (BCL-2-related ovarian killer) integrate into a model of the mitochondrial pathway of apotosis? - How do mitochondrial membrane proteins impact on the release of cytochrome c? - How do mitochondrial dynamics and metabolism impact MOMP? Since the evolution of multicellular species, the decision of a cell to live or to die in response to a potential threat to its functional coherence has become important not only for the individual cell itself but also for the cell’s community – the tissues, organs, and organism. Ongoing research into the biology of cell death uncovered effector mechanisms that enable us to classify different cell death pathways. Broadly, these are often divided into three major types of cell death: apoptosis, autophagy, and necrosis,1, 2, 3, 4 although the second remains poorly understood (and often misinterpreted). The fact that cell death can take place in a programmed and ordered way, as in apoptosis and regulated necrosis (e.g., necroptosis), provides a potential opportunity to manipulate the cell fate choice between death or survival. However, the exploitation of cell death pathways for long-term therapeutic benefit requires an in-depth understanding of the molecular mechanisms underpinning cell death and their (patho)physiological relevance. Apoptosis occurs predominantly via two main pathways, often referred to as the extrinsic and the intrinsic pathways, depending on the apoptosis-initiating signal (Figure 1).5 The extrinsic pathway is initiated via death receptors (DRs) at the cell membrane. The intrinsic (mitochondrial) pathway, on the other hand, is controlled by the BCL-2 protein family and is executed by mitochondrial outer membrane permeabilization (MOMP). Both pathways lead to the activation of cysteine proteases, specific for aspartic acid residues, that is, caspases.6 Ultimately, caspase-3 and -7, the executioners of apoptosis, cleave more than 1000 different proteins leading to their degradation or activation. This in turn affects physiological processes including chromatin 'remodeling', manipulation of signaling pathways, deformation of the cytoskeleton, and exposure of signals for phagocytosis and clearance of the dying cell.7, 8 As a result of this multitude of enzymatic reactions, apoptotic cells display a typical phenotype characterized by chromatin condensation (pyknosis), cell shrinkage, and membrane blebbing.9 [Figure: The extrinsic and intrinsic apoptotic pathways. The extrinsic pathway is initiated by engagement of DRs via their respective ligands TNF, FASL/CD95L, or TRAIL. Together with the adaptor FAS-associated death-domain (FADD) protein and the initiator procaspase-8 (or -10) they form the death-inducing signaling complex (DISC). This assembly enables the dimerization and autoactivation of the initiator caspases, which in turn cleave and activate the executioner caspase-3 and -7, ultimately leading to apoptosis unless they are inhibited by XIAP. The intrinsic pathway can be engaged by diverse intracellular stresses that modulate BCL-2 family protein interactions that control the activation of the BCL-2 effector proteins BAX and BAK. Once activated, BAX and BAK cause MOMP, leading to the release of proapoptotic IMS proteins. Cytochrome c (Cyt c) engages APAF1 and induces its oligomerization, leading to apoptosome formation that recruits and activates the initiator procaspase-9. Active caspase-9 cleaves and activates the executioner caspase-3 and -7. Simultaneously with Cyt c, Smac is released from the IMS and inhibits XIAP. The extrinsic and intrinsic pathways are linked; caspase-8 can cleave the BH3-only protein BH3-interacting domain death agonist (Bid), leading to its active, truncated form tBid, which in turn activates BAX/BAK. Numbers in circles indicate the respective pro- and active caspase; interrupted circles represent active caspases] Predominant in vertebrate cells is the intrinsic pathway of apoptosis in which diverse forms of cell stressors can modulate the composition and/or activation status of pro- and antiapoptotic Bcl-2 family members. These in turn engage MOMP, generally via the BCL-2 effector proteins BCL-2-associated X protein (BAX) and BCL-2 antagonist or killer (BAK). MOMP results in the release of proapoptotic intermembrane space (IMS) proteins that promote the formation of a molecular complex called the apoptosome, leading to caspase-9 engagement and caspase-3 and -7 activation.2 The extrinsic pathway can be activated by ligand binding of a subset of the TNF receptor superfamily, including TNFR1, TRAIL receptors (DR4 and DR5) and Fas (Apo-1; CD95).3 This leads to the activation of caspase-8 and, as in the intrinsic pathway, ultimately to the engagement of caspase-3 and -7. Cells that are susceptible to apoptosis via direct activation of the caspase cascade by the extrinsic pathway, such as T lymphocytes, are designated type 1 cells. However, often the extrinsic pathway independent of MOMP is not sufficient to trigger cell death; a crosstalk between the extrinsic and intrinsic pathways exists that can amplify the extrinsic signal.10 For this purpose, caspase-8 cleaves the proapoptotic Bcl-2 protein BID to tBID (truncated), which then activates BAX and BAK.11 Cells that require this interaction for extrinsic apoptosis are referred to as type 2 cells (e.g., hepatocytes, pancreatic cells). Characterization of the crucial players and interactions of the intrinsic pathway of apoptosis is of ongoing intense research effort, aiming to target the apoptosis machinery for successful clinical translation. Most recently, highly valuable mechanistical insights into BCL-2 family interactions enabled the development of cancer therapies, including the bona fide BH3-mimetic drugs (Navitoclax), a highly selective BCL-2 inhibitor (Venetoclax), and MCL-1 inhibitors.12, 13, 14 In addition to their therapeutical use, BH3 profiling of tumors has also been proposed as a 'biomarker' strategy for the prediction of chemotherapy sensitivity.15, 16, 17 Dissecting the mechanisms underlying apoptosis will allow us to exploit programmed cell death for the treatment of human diseases. Here we review the central player of apoptosis, the mitochondrion, before highlighting the most recent insights into the Bcl-2 effector molecules causing MOMP. Finally, we